NewsRoom Articles - Page 1270 of 1352

MondayFeb 13, 2017 11:36 am

SeeThruEquity Projects Moxian, Inc. (NASDAQ: MOXC) Revenues at Greater Than $40 Million by FY2019

SeeThruEquity initiated coverage of Moxian, Inc. (NASDAQ: MOXC) on February 8, 2017, projecting that the China-based company will achieve annual revenues of more than $40 million by FY2019 alongside EBITDA of $17.456 million. The investment research firm set a price target of $4.50 for the company’s stock (http://nnw.fm/Kb4Rn). Moxian is focused on the $48 billion (1H2017) O2O market, according to the SeeThruEquity report, quoting investment materials from the company. Moxian’s platform, Moxian+, targets small- and medium-sized businesses in the O2O market in China. Moxian offers consumers the ability, through mobile, social media, and online channels, to purchase online and pay…

MondayFeb 13, 2017 11:04 am

eXp World Holdings, Inc. (EXPI) Set to Capitalize on Canadian Real Estate Market Interest Following U.S. Presidential Election

According to a just-published article by Royal Lepage (http://nnw.fm/0YBTu), Canada’s leading real estate services provider, there has been a verified surge of American interest in Canadian real estate following the recent presidential election. The company reported an increase in searches into the Canadian real estate market from across the United States. Although the United States has always been a top source for immigration into Canada, the past year has seen a significant increase in U.S. traffic on the Royal Lepage website. The site reported an increase of just under 74% compared to the same period in 2015. In addition, according…

MondayFeb 13, 2017 10:17 am

NetworkNewsWire Provides Coverage of 19th BIO CEO & Investor Conference

NetworkNewsWire (“NNW”) is providing coverage of the companies presenting at the ongoing BIO CEO & Investor Conference in New York City. Taking place February 13-14, the BIO CEO & Investor Conference focuses on established and emerging public and private companies in the biotech space. Among other highlights, conference attendees are privy to Washington’s perspective on how the Trump Administration will address ACA, CMS and PDUFA VI; will learn about clinical developments and industry catalysts via workshops and business roundtables; can attend “Fireside chats” between biopharma executives; and have the opportunity to evaluate investment opportunities in the biotech space. As a…

FridayFeb 10, 2017 2:01 pm

CytoDyn Inc. (CYDY) PRO 140 – A Promising Entry in the Treatment of HIV

The upcoming Conference On Retroviruses And Opportunistic Infections, to be held at the Washington State Convention Center in Seattle from February 13-16, 2017, is billed to feature a heavyweight clash between GlaxoSmithKline (NYSE: GSK) and Gilead Sciences (NASDAQ: GILD) for the treatment of HIV patients (http://nnw.fm/05mzG). Gilead is expected to present data from mid-stage Phase II testing of bictegravir, an integrase inhibitor similar to GSK’s dolutegravir. The GSK product, marketed as Tivicay, has enjoyed wide success, gaining approval not only in the U.S. but in Canada and the European Union as well. Its success restored GSK’s dominant position in the…

ThursdayFeb 09, 2017 3:56 pm

Moxian, Inc. (NASDAQ: MOXC) Receives Initial Coverage from SeeThruEquity, Price Target Set at $4.50

Leading independent equity research firm SeeThruEquity on February 8, 2017, announced that it has initiated coverage of China’s Moxian, Inc. (NASDAQ: MOXC), with a price target of $4.50 over the next 12 months, according to a press release (http://nnw.fm/Myy0B) from the equity firm. Based in Shenzhen, China, Moxian has quickly developed into one of the Asian nation’s top providers of sales and marketing solutions aimed at helping online vendors connect with customers, with a focus on social media integration and the fast-growing online-to-offline market. SeeThruEquity, which focuses on small- and micro-cap public companies, also released an initial coverage report for…

ThursdayFeb 09, 2017 2:59 pm

Stealth Technologies (STTH) is Leading Innovation in Security and Personal Protection Products

Stealth Technologies, Inc. (OTCQB: STTH) is an innovative technology based company focused on emerging technology product development, marketing and sales, with a portfolio of products and intellectual property in the personal financial protection and data protection verticals. The company has developed a suite of products to protect against “electronic pickpockets”, emergency response latency, credit fraud protection and cell phone data protection. The company also has several other products under development and is exploring potential military applications of its proprietary technologies. Stealth had significant success in several new product launches during 2016, including: Unit sales in excess of 221,000 units of…

ThursdayFeb 09, 2017 12:38 pm

National Waste Management Holdings, Inc. (NWMH) Aiming to Become Market Leader via Aggressive Growth and Acquisition Strategy

Florida-based National Waste Management Holdings, Inc. (OTC: NWMH), a professional waste management and recycling operator offering a wide range of relevant services, is one step closer to achieving its declared goal of becoming a market leader via its aggressive acquisition strategy and organic growth, after acquiring another company and successfully expanding its activity in upstate New York. National Waste Management Holdings plans to continue growing at the same pace, as it plans to finalize at least one acquisition per quarter and already has a few acquisitions lined up for the year. Operating a vertically integrated waste management service, National Waste…

ThursdayFeb 09, 2017 9:13 am

ChineseInvestors.com, Inc. (CIIX) Aiming to Help Tackle Epilepsy with a CBD Oil-Based Pharmaceutical

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company in the business of providing Chinese-speaking investors with real-time market analysis, commentary, and educational services, recently announced its goals for 2017, stating that it plans to develop a CBD oil-based pharmaceutical that could help with the major problem of epilepsy in China. CBD, also known as cannabidiol, is one of the most important healing substances in the hemp plant, helping treat inflammation, convulsions, insomnia, anxiety, ulcers, neuropathic pain, and epilepsy, among other medical problems. The difference between CBD and THC is that THC is classified as a federally controlled psychotropic drug, whereas CBD is…

WednesdayFeb 08, 2017 1:45 pm

Social Reality, Inc. (NASDAQ: SRAX) Targeting Two Multi-Billion Dollar Digital Ad Markets

Social Reality, Inc. (NASDAQ: SRAX) is an internet advertising firm that sees opportunity in the worldwide real-time bidding (RTB) market, which is expected to grow to $42 billion by 2018, according to a study by ReportsnReports.com (http://nnw.fm/u59Ho). The same study indicates that the RTB market is also expected to demonstrate a 41% CAGR from 2014-2019. Chris Miglino, CEO and founder of Social Reality, Inc., oversees some 120 employees worldwide and is also guiding the company in the social media market. eMarketer (http://nnw.fm/uvDL1) projects that worldwide social media advertising will reach $35.98 billion by 2017. That figure will account for 16%…

WednesdayFeb 08, 2017 1:00 pm

CytoDyn Inc. (CYDY) is Tackling HIV Differently

Nestled on the north bank of the Columbia River in the State of Washington is the city of Vancouver, home to CytoDyn Inc. (OTCQB: CYDY). A publicly-held biotech company, CytoDyn manages its efforts to improve the lives of men and women with the human immunodeficiency virus (HIV), focusing its attention on developing new therapies that offer flexibility and freedom to members of this global community. With its lead clinical drug candidate, PRO 140, CytoDyn is aiming to offer the next class of antiviral agents for the treatment of HIV. The drug, a monoclonal antibody, is designed to block HIV from…

Financial news and publishing for public and private companies

Contact us: 512.354.7000